The Patient-Physician-Industry-Government Partnership: A Societal Good

American Journal of Medicine

Volumn 122, Issue 10, 2009, Pages 886-887

  Frishman, William H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; FUROSEMIDE; GUANETHIDINE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIDOCAINE; METHYLDOPA; NITRATE; PROCAINAMIDE; QUINIDINE; RESERPINE;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; DOCTOR PATIENT RELATION; DRUG ELUTING STENT; DRUG INDUSTRY; DRUG MARKETING; ECONOMIC ASPECT; EDITORIAL; GOVERNMENT; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEDICAL PRACTICE; MORTALITY; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; PUBLIC FIGURE; SMOKING;

ACADEMIC MEDICAL CENTERS; BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; DRUG INDUSTRY; GOVERNMENT; HUMANS; INTERPROFESSIONAL RELATIONS; NATIONAL INSTITUTES OF HEALTH (U.S.); PHYSICIAN-PATIENT RELATIONS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 70349318424     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.07.012     Document Type: Editorial

References (4)

1. Relman A.S., and Angell M. America's other drug problem. The New Republic (December 16, 2002) 27-41
2. Alpert J.S. Doctors and the drug industry: how can we handle potential conflicts of interest?. (editorial). Am J Med 118 (2005) 99-100
3. Blumenthal D. Doctors and drug companies. N Engl J Med 351 (2004) 1885-1890
4. Ross J.S., Keyhani S., and Korenstein D. Appropriateness of collaborations between industry and the medical profession: physicians' perceptions. Am J Med 122 (2009) 955-960